DNH

Financial BO

Goods

Medicines

Rate contract for purchase of Tablets

UT Administration of Dadra and Nagar Haveli

CPB, Poom No.21DNH, Silvassa | Dadra And Nagar Haveli, The Dadra And Nagar Haveli And Daman And Diu

Amount: Refer DocsCloses: 29 Aug 2022Closed

Timeline

Published23 Aug 2022
Closed29 Aug 2022
Technical Evaluation8 Sept 2022
Financial Evaluation8 Sept 2022
Award—

Bids

8 Bids8 Sept 2022

#	Company	Status
1	amishpharma Admitted-Finance	Admitted-Finance
2	B PARIKH AND COMPANY Admitted-Finance 3 MAHESH APPARTMENT NR HIMMATLAL PARK BRTS STOP AMBAWADI SATELLITE AHMEDABAD GUJARAT 380015 \| AHMADABAD \| GUJARAT \| 380015	Admitted-Finance
3	DRASHTI MEDILINK Admitted-Finance	Admitted-Finance
4	Keps Pharma Admitted-Finance	Admitted-Finance
5	Mehta Trading Co Admitted-Finance 331 DR NATH PAI ROAD OPP DOCKYARD STATION MAZAGAON MUMBAI MAHARASHTRA 400010 \| MUMBAI SUBURBAN \| MAHARASHTRA \| 400010	Admitted-Finance

Tender Value

Refer Docs

EMD Value

₹54,503

Closing Date

29 Aug 2022, 2:00 pmClosed

Tender Inviting Organisation

Name

Incharge, Central Procurement Branch, DNH and DD

Address

Central Procurement Branch, 3rd Floor, Room No. 21, Secretariat, Silvassa- 396 230.

Work Description

Purchase of Tablets

Tender Information

Tender ID

2022_UTDNH_6092_1

Reference Number

CPB/DNHDD/Tablets/095/1156

Tender Type

Open Tender

Product Category

Medicines

Form of Contract

Item Wise

Period of Work

90 days

Location

CPB, Poom No.21DNH, Silvassa

Source Website

Subscribe to view

Eligibility / Pre-Qualification

Please refer Tender documents.

Documents Required

14 documents required · 14 mandatory

Fee

RequiredTender Fee (.pdf)

RequiredEMD (.pdf)

PreQual/Technical

RequiredPAN No. (.pdf)

RequiredGST Registration. (.pdf)

RequiredValid License in the Field of Supply (.pdf)

RequiredPartnership Deed/ Memorandum/ Registration of Firm, etc. (.pdf)

RequiredCA Certified Average Annual Turnover of Rs 7.00 Lakhs in last 03 Financial Years. (.pdf)

RequiredVerification, Undertaking, Checklist and Documents as per Annexure-A (.pdf)

RequiredScan copy of Terms and Conditions of the tender documents duly Stamped and Signed on each page (.pdf)

RequiredScan copy of Scope of Work correctly filled with Stamped and Signed on each page. (.pdf)

RequiredFresh Affidavit on Stamp Paper for this Tender Acceptance of Tender at point (N) (.pdf)

RequiredScan copy of Annexure B of the Tender Documents duly Stamped and Signed (.pdf)

RequiredCopy of certificate of USFDA/CE for the quoted product (.pdf)

Finance

RequiredFinance (.xls)

Fee & Financial Details

Tender Fee Amount

₹1,000

Tender Fee Payable To

Office of DNH

EMD Fee Amount

₹54,503

Important Dates

Last Activity

8 Sept 2022

Published

23 Aug 2022

Bid Opening

29 Aug 2022

Download Starts

23 Aug 2022

Download Ends

29 Aug 2022

Submission Starts

23 Aug 2022

BOQ Preview

•

Rate Contract for Purchase of Tablets for Department of Health and Family Welfare, DNH & DD : (Specifications as per Tender Documents)

•

Tab.Azithromycin 500mg

•

Tab.Calcium Carbonate1000mg + Magnesium Hydroxide 250mg + Zinc Sulphate Monohydrate + Vitamin D3

•

Tab.Cefixime 200mg

•

Tab.Metformin 500 mg

•

Tab.Paracetamol 500mg

•

Tab.Atomoxetine 18mg

•

Tab.Methylphenidate 10mg

•

Keps Pharma

•

Mehta Trading Co

•

B PARIKH AND COMPANY

•

amishpharma

•

DRASHTI MEDILINK

•

Shiva Medical Agencies

•

PARIDHI AGENCIES

Stage Documents

Stage Summary Snapshot

stage.html

html • 0.04 MB

Technical Evaluation

tech_eval.pdf

PDF

Financial Bid Opening

boq_comp_chart.xlsx

xlsx

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.03 MB

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .